Form 8-K - Current report:
SEC Accession No. 0001193125-20-261480
Filing Date
2020-10-01
Accepted
2020-10-01 17:30:01
Documents
13
Period of Report
2020-09-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d190494d8k.htm   iXBRL 8-K 25435
  Complete submission text file 0001193125-20-261480.txt   178990

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20200929.xsd EX-101.SCH 3448
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20200929_def.xml EX-101.DEF 13461
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200929_lab.xml EX-101.LAB 22016
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200929_pre.xml EX-101.PRE 14259
6 EXTRACTED XBRL INSTANCE DOCUMENT d190494d8k_htm.xml XML 5105
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 201217244
SIC: 2834 Pharmaceutical Preparations